Samy Jambon

4PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 03, 2024
CD33-CD123 IF-THEN Gating Reduces Toxicity while Enhancing the Specificity and Memory Phenotype of AML-Targeting CAR-T Cells.

Samy Jambon, Jianping Sun, Shawn Barman

|Jan 22, 2021
Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma.

Babak Moghimi, Sakunthala Muthugounder, Samy Jambon

|Jan 16, 2019
Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model.

Sabine Depauw, Mélanie Lambert, Samy Jambon

|Jun 21, 2018
Targeting Transcription Factors for Cancer Treatment.

Mélanie Lambert, Samy Jambon, Sabine Depauw

Pageof 1

Frequent Collaborators

2 joint publications

Mélanie Lambert

2 joint publications

Marie-Hélène David-Cordonnier

1 joint publications

Sabine Depauw

1 joint publications

W David Wilson